Literature DB >> 16943403

Marburg hemorrhagic fever associated with multiple genetic lineages of virus.

Daniel G Bausch1, Stuart T Nichol, Jean Jacques Muyembe-Tamfum, Matthias Borchert, Pierre E Rollin, Hilde Sleurs, Patricia Campbell, Florimund K Tshioko, Catherine Roth, Robert Colebunders, Patricia Pirard, Simon Mardel, Loku A Olinda, Hervé Zeller, Antoine Tshomba, Amayo Kulidri, Modeste L Libande, Sabue Mulangu, Pierre Formenty, Thomas Grein, Herwig Leirs, Leo Braack, Tom Ksiazek, Sherif Zaki, Michael D Bowen, Sheilagh B Smit, Patricia A Leman, Felicity J Burt, Alan Kemp, Robert Swanepoel.   

Abstract

BACKGROUND: An outbreak of Marburg hemorrhagic fever was first observed in a gold-mining village in northeastern Democratic Republic of the Congo in October 1998.
METHODS: We investigated the outbreak of Marburg hemorrhagic fever most intensively in May and October 1999. Sporadic cases and short chains of human-to-human transmission continued to occur until September 2000. Suspected cases were identified on the basis of a case definition; cases were confirmed by the detection of virus antigen and nucleic acid in blood, cell culture, antibody responses, and immunohistochemical analysis.
RESULTS: A total of 154 cases (48 laboratory-confirmed and 106 suspected) were identified (case fatality rate, 83 percent); 52 percent of cases were in young male miners. Only 27 percent of these men reported having had contact with other affected persons, whereas 67 percent of patients who were not miners reported such contact (P<0.001). Most of the affected miners (94 percent) worked in an underground mine. Cessation of the outbreak coincided with flooding of the mine. Epidemiologic evidence of multiple introductions of infection into the population was substantiated by the detection of at least nine genetically distinct lineages of virus in circulation during the outbreak.
CONCLUSIONS: Marburg hemorrhagic fever can have a very high case fatality rate. Since multiple genetic variants of virus were identified, ongoing introduction of virus into the population helped perpetuate this outbreak. The findings imply that reservoir hosts of Marburg virus inhabit caves, mines, or similar habitats. Copyright 2006 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943403     DOI: 10.1056/NEJMoa051465

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  86 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method.

Authors:  Yohei Kurosaki; Allen Grolla; Aiko Fukuma; Heinz Feldmann; Jiro Yasuda
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.

Authors:  Baocheng Liu; Shishang Dong; Guobang Li; Wenming Wang; Xiang Liu; Yantong Wang; Cheng Yang; Zihe Rao; Yu Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

4.  Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.

Authors:  Veronica V Nicholas; Rebecca Rosenke; Friederike Feldmann; Dan Long; Tina Thomas; Dana P Scott; Heinz Feldmann; Andrea Marzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

5.  Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.

Authors:  Paul Roddy; Sara L Thomas; Benjamin Jeffs; Pascoal Nascimento Folo; Pedro Pablo Palma; Bengi Moco Henrique; Luis Villa; Fernando Paixao Damiao Machado; Oscar Bernal; Steven M Jones; James E Strong; Heinz Feldmann; Matthias Borchert
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

7.  Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008.

Authors:  Gilda Grard; Roman Biek; Jean-Jacques Muyembe Tamfum; Joseph Fair; Nathan Wolfe; Pierre Formenty; Janusz Paweska; Eric Leroy
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

8.  Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

Authors:  Lauren M Smith; Lisa E Hensley; Thomas W Geisbert; Joshua Johnson; Andrea Stossel; Anna Honko; Judy Y Yen; Joan Geisbert; Jason Paragas; Elizabeth Fritz; Gene Olinger; Howard A Young; Kathleen H Rubins; Christopher L Karp
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

9.  Studies of reservoir hosts for Marburg virus.

Authors:  Robert Swanepoel; Sheilagh B Smit; Pierre E Rollin; Pierre Formenty; Patricia A Leman; Alan Kemp; Felicity J Burt; Antoinette A Grobbelaar; Janice Croft; Daniel G Bausch; Hervé Zeller; Herwig Leirs; L E O Braack; Modeste L Libande; Sherif Zaki; Stuart T Nichol; Thomas G Ksiazek; Janusz T Paweska
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

10.  Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.

Authors:  Jonathan S Towner; Brian R Amman; Tara K Sealy; Serena A Reeder Carroll; James A Comer; Alan Kemp; Robert Swanepoel; Christopher D Paddock; Stephen Balinandi; Marina L Khristova; Pierre B H Formenty; Cesar G Albarino; David M Miller; Zachary D Reed; John T Kayiwa; James N Mills; Deborah L Cannon; Patricia W Greer; Emmanuel Byaruhanga; Eileen C Farnon; Patrick Atimnedi; Samuel Okware; Edward Katongole-Mbidde; Robert Downing; Jordan W Tappero; Sherif R Zaki; Thomas G Ksiazek; Stuart T Nichol; Pierre E Rollin
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.